Click on each picture for a larger view.
Representative Mark Foley (R-FL)
with NORD President Abbey Meyers
Linda A. Suydam, DPA (left), Senior Associate Commissioner, FDA
Marlene Haffner, MD, Director, FDA Office of Orphan Products Development
Frank Sasinowski, Hyman, Phelps & McNamara and NORD Board of Directors
Michael Astrue, General Counsel, Transkaryotic Therapies, Inc., presenting "check" representing TKT's support for second year of NORD/Roscoe Brady Lysosomal Storage Diseases Fellowships to Abbey Meyers, as Dr. Brady looks on
Karen Ball, CEO & Founder, Sturge-Weber Foundation and NORD Board of Directors
Abbey Meyers
Dr. Daniel Vasella, CEO, Novartis Pharmaceuticals
Kimberly Symonds, of Families of Spinal Muscular Atrophy and NORD Board of Directors
Richard Rylander, Director of Field Operations, Actelion Pharmaceuticals US Inc.
Estelle Benson, Executive Director, Guillain Barre Syndrome Foundation International and NORD Board of Directors
Richard Love of Ilex
Desiree Lyon, Executive Director, American Porphyria Foundation and NORD Board of Directors
Bill Hatfield, Millennium
Abbey Meyers
Maria Hardin, NORD Vice President of Patient Services
David Brennan, President AstraZeneca
James Broatch, Chair Executive Director, Reflex Sympathetic Syndrome Association of America and Chair, NORD Board of Directors
Jean Campbell, NORD Vice President of Development
Marty Allen, Patient Link Coordinator, Medtronic Foundation
C. Kenneth Mehrling, Chief Operating Officer, Sigma-Tau Pharmaceuticals and Master of Ceremonies for the Banquet
Sigma Tau staff members Justina Lambert and Lesli King
Sami Said, Chairman of NORD's Medical Advisory Committee (center)
Garrett Bergman, MD, of the Medical Advisory Committee and Mrs. Bergman
Check here to read about events on Capitol Hill, funding for rare-disease research, and other topics of interest from NORD's office in Washington, DC.)
)
)
)
)
)
)
)
)
)
